CHK2 Activation Contributes to the Development of Oxaliplatin Resistance in Colorectal Cancer

A proteomic screen was performed to reveal altered protein kinase phosphorylation in oxaliplatin-resistant colorectal cancer (CRC) tumor spheroids. The function of CHK2 was characterised using several biochemical techniques and evident using in vitro cell and in vivo tumor models.